Mirum Pharmaceuticals (MIRM) Net Cash Flow (2019 - 2026)

Mirum Pharmaceuticals' Net Cash Flow history runs 8 years deep, the most recent figure standing at $29.7 million for Q1 2026.

• In Q1 2026, Net Cash Flow rose 353.47% year-over-year to $29.7 million; the TTM figure through Mar 2026 stood at $113.5 million (up 225.77% YoY), while the FY2025 annual figure was $72.0 million, up 215.96% from the prior year.
• Net Cash Flow was $29.7 million for Q1 2026 at Mirum Pharmaceuticals, up from $16.1 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $147.9 million in Q2 2023 to a low of -$69.2 million in Q2 2024.
• Historically, Net Cash Flow has averaged $11.5 million across 5 years, with a median of $9.0 million in 2022.
• The sharpest annual moves came in 2024 and 2025: Net Cash Flow slumped 265.78% in 2024, then jumped 1660.35% in 2025.
• A 5-year view of Net Cash Flow shows it stood at -$7.8 million in 2022, then tumbled by 114.78% to -$16.8 million in 2023, then jumped by 105.42% to $913000.0 in 2024, then surged by 1660.35% to $16.1 million in 2025, then soared by 85.09% to $29.7 million in 2026.
• The last three Net Cash Flow figures came in at $29.7 million (Q1 2026), $16.1 million (Q4 2025), and $53.6 million (Q3 2025), per Business Quant data.